Abstract

Background: Hepatopulmonary syndrome (HPS) is a characterized by abnormalities in blood oxygenation secondary to the presence of intrapulmonary vascular dilations (IPVD) in the setting of end-stage liver disease. Hepatopulmonary syndrome (HPS) affects 10–32 % of patients with cirrhosis and is defined by liver abnormalities, intrapulmonary vascular dilatations (IPVDs), and abnormal oxygenation. Aim and Objectives: The aim of study to detect the Hepatopulmonary syndrome by using bubble contrast Echocardiography in patients with cirrhosis with reference to arterial hypoxemia. Material and Methods: This is a prospective study was done from September 2022 to August 2023 in Shyam Shah Medical College and Sanjay Gandhi hospital Rewa M.P. All patients with the end stage liver disease were evaluated for the presence of hepatopulmonary syndrome by arterial blood gas analysis and bubble contrast echocardiography. In addition, all the patients underwent routine blood tests, pulse oximetry, chest X-rays, pulmonary function test, and diffusion capacity of the lungs for carbon monoxide (DLCO).

Description